News & Insights | Informa Connect

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

AI and alternatives: How are asset and wealth management leaders adapting to game-changing trends?

A roaring return to Riyadh: Relive SuperReturn Saudi Arabia 2026!

Innovation Statement – a call to global biotechnology action

How to unlock human potential: Insights from Gitanjali Trevorrow-Seymour

What do leaders need to keep in mind during global uncertainty?

Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week

BIO-Europe® Innovation Statement

Leadership, risk, and thriving at uncertain times with Major Tim Peake

Mastering risk and decision making: Insights from former professional poker player Caspar Berry

AI transformation theater: What CEOs must do differently

eTourism Moves: New Hires & Promotions for February

National Restaurant Association Show Reinforces Workforce Investment with 2026 Young Professionals Scholarship Program

Sanofi acquires Dynavax for $2.2bn, adding Hepatitis B vax and shingles candidate

Zejing’s DLL3 cancer drug goes global with AbbVie co-sign

Merck reportedly in talks to buy Revolution in huge $28–32bn deal

Rumor has it: Sanofi eyes higher bid for retinal drug developer

Double take: Novartis signs back-to-back licensing agreements

Eikon Therapeutics sets sights on public markets

Parabilis Medicines’ latest financing round causes IPO whispers

Medline targets $5.37bn in landmark IPO

Quick Links